These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5733537)

  • 1. [Therapeutic effect of gabob in a group of patients with character disorders].
    Colucci D'Amato F
    Osp Psichiatr; 1968; 36(3):478-84. PubMed ID: 5733537
    [No Abstract]   [Full Text] [Related]  

  • 2. [The GABOB in pediatric neuropsychiatry. Indications and results].
    Cavazzuti GB
    Clin Ter; 1969 Mar; 48(6):515-24. PubMed ID: 5404652
    [No Abstract]   [Full Text] [Related]  

  • 3. [Statistical analysis of the results obtained with prolonged treatment with gamma-amino-beta-hydroxybutyric acid of character disorders].
    Ferro-Milone F; Toschi P; Lorizio A
    Riv Neurobiol; 1966; 12(3):267-97. PubMed ID: 4860044
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the current possibilities of drug therapy of drug therapy of abnormalities of behavior of the character type in infants and children].
    Zucchi M
    Minerva Med; 1970 Oct; 61(82):4542-50. PubMed ID: 5474918
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the clinical pharmacology of an association of gamma-amino-beta-hydroxybutyric acid and plant extracts used in therapy of children with behavior disorders and sleep disorders].
    Cavazzuti GB
    Clin Ter; 1969 Oct; 51(1):15-29. PubMed ID: 5370056
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of amitryptyline drops, in ambulatory therapy, on behavior and character disorders in children and adolescents].
    Sallou C
    Rev Neuropsychiatr Infant; 1969 Dec; 17(12):859-64. PubMed ID: 5369060
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of a combination of GABOB and plant extracts on the behavior of hospitalized children].
    Di Marco A
    Minerva Pediatr; 1972 Dec; 24(43):2150-61. PubMed ID: 4652220
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic effects of gamma-aminobutyric acid (GABA) and gamma-amino-beta-hydroxybutyric acid (GABOB)].
    Maccari M; Maggi GC
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):Suppl:1917-21. PubMed ID: 5875466
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of stimulant drugs in learning and behavior disorders.
    Conners CK
    Psychopharmacol Bull; 1971 Jul; 7(3):39-40. PubMed ID: 5117857
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-experimental studies in the treatment of epilepsy with GABOB-diazepam].
    Tartara A; Arrigo A; Scamoni C; Presazzi A
    Minerva Med; 1973 May; 64(36):1943-8. PubMed ID: 4578343
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical data on a drug with a base of gamma-aminobutyric acid and vitamin B6 in the treatment of cerebral paralysis, oligophrenia and behavior disorders in children].
    Hoineff S
    Hospital (Rio J); 1968 May; 73(5):1653-7. PubMed ID: 5308767
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations on electroencephalographic abnormalities of epileptic patients treated with GABOB].
    D'Errico A; Di Perri R
    Rass Neuropsichiatr; 1964; 18(4):370-8. PubMed ID: 5319046
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and statistical evaluation of GABOB in behavior disorders in young children].
    Amore F; Cavazzuti GB
    Minerva Med; 1971 Apr; 62(29):1503-13. PubMed ID: 4936825
    [No Abstract]   [Full Text] [Related]  

  • 14. Lithium treatment of impulsive behavior in children.
    Siassi I
    J Clin Psychiatry; 1982 Dec; 43(12):482-4. PubMed ID: 6819289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disorders of character in the evolutive age. (Review and personal considerations)].
    Mastrangelo G
    Osp Psichiatr; 1967; 35(2):365-84. PubMed ID: 4882317
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with drug therapy of aggressive behavior of psychogenic origin during the evolutive age].
    Frattegiani A; Fracassini F
    Arch Ital Pediatr Pueric; 1969; 26(5):347-53. PubMed ID: 5408166
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of character disorders with a new butyrophenone: R. 3345 or pipamperone].
    Fouks ; Mathis ; Gilbert ; Ferragu ; Houssait ; Lerno
    Ann Med Psychol (Paris); 1966 Dec; 124(5):677-81. PubMed ID: 5973302
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and psychometric observations on the therapeutic effect of an association of GABA-1-glutamine-aspartate-pyridoxal-phosphate in a group of psychoneurotic neurasthenic patients].
    Fabiani F; Martini P; Franceschi-Biagiotti F
    Riv Neurobiol; 1969; 15(1):35-62. PubMed ID: 5399614
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of schizophrenia using GABOB].
    Ono S; Yashima K; Mori Y; Ueno B; Yashima Y; Takaya Y; Mizushima S; Aono T; Someno I
    Hospital (Rio J); 1968 Nov; 74(5):1499-504. PubMed ID: 5305328
    [No Abstract]   [Full Text] [Related]  

  • 20. An update on the use of lithium carbonate in aggressive children and adolescents with conduct disorder.
    Campbell M; Kafantaris V; Cueva JE
    Psychopharmacol Bull; 1995; 31(1):93-102. PubMed ID: 7675995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.